The toxicology screening systems market is projected to grow from USD 6,366.0 million in 2026 to USD 13,617.0 million by 2036, at a CAGR of 7.9%. Reference laboratories will dominate with a 26.0% market share, while workplace drug testing will lead the applications segment with a 28.0% share.